Literature DB >> 8544184

The myotubular myopathies: differential diagnosis of the X linked recessive, autosomal dominant, and autosomal recessive forms and present state of DNA studies.

C Wallgren-Pettersson1, A Clarke, F Samson, M Fardeau, V Dubowitz, H Moser, T Grimm, R J Barohn, P G Barth.   

Abstract

Clinical differences exist between the three forms of myotubular myopathy. They differ regarding age at onset, severity of the disease, and prognosis, and also regarding some of the clinical characteristics. The autosomal dominant form mostly has a later onset and milder course than the X linked form, and the autosomal recessive form is intermediate in both respects. These differences are, however, quantitative rather than qualitative. Muscle biopsy studies of family members are useful in some cases, and immunohistochemical staining of desmin and vimentin may help distinguish between the X linked and autosomal forms. Determining the mode of inheritance and prognosis in individual families, especially those with a single male patient, still poses a problem. Current molecular genetic results indicate that the gene for the X linked form is located in the proximal Xq28 region. Further molecular genetic studies are needed to examine the existence of genetic heterogeneity in myotubular myopathy and to facilitate diagnosis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8544184      PMCID: PMC1051665          DOI: 10.1136/jmg.32.9.673

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  48 in total

1.  Vimentin and desmin in maturing skeletal muscle and developmental myopathies.

Authors:  H B Sarnat
Journal:  Neurology       Date:  1992-08       Impact factor: 9.910

2.  Centronuclear myopathy--an inherited neuromuscular disorder. A report of 3 cases.

Authors:  H Isaacs; M E Badenhorst
Journal:  S Afr Med J       Date:  1991-09-07

Review 3.  [Autosomal dominant centronuclear myopathy].

Authors:  X Ferrer; C Vital; M Coquet; B Deleplanque; E Ellie; A Lagueny; J Julien
Journal:  Rev Neurol (Paris)       Date:  1992       Impact factor: 2.607

4.  Report on the 20th ENMC sponsored international workshop: myotubular/centronuclear myopathy.

Authors:  C Wallgren-Pettersson; N S Thomas
Journal:  Neuromuscul Disord       Date:  1994-01       Impact factor: 4.296

5.  Myopathy with pathological features of both centronuclear myopathy and multicore disease.

Authors:  R B Fitzsimons; J G McLeod
Journal:  J Neurol Sci       Date:  1982-12       Impact factor: 3.181

6.  X linked myotubular myopathy (MTM1) maps between DXS304 and DXS305, closely linked to the DXS455 VNTR and a new, highly informative microsatellite marker (DXS1684).

Authors:  N Dahl; F Samson; N S Thomas; L J Hu; W Gong; G Herman; J Laporte; P Kioschis; A Poustka; J L Mandel
Journal:  J Med Genet       Date:  1994-12       Impact factor: 6.318

7.  Genuine myotubular myopathy.

Authors:  L Edström; R Wróblewski; W G Mair
Journal:  Muscle Nerve       Date:  1982-10       Impact factor: 3.217

8.  Crural hypertrophy associated with centronuclear myopathy.

Authors:  P Bill; G Cole; N S Proctor; D Saffer; A Botes
Journal:  J Neurol Neurosurg Psychiatry       Date:  1979-06       Impact factor: 10.154

9.  Myotubular myopathy in a girl with a deletion at Xq27-q28 and unbalanced X inactivation assigns the MTM1 gene to a 600-kb region.

Authors:  N Dahl; L J Hu; M Chery; M Fardeau; S Gilgenkrantz; A Nivelon-Chevallier; I Sidaner-Noisette; F Mugneret; J B Gouyon; A Gal
Journal:  Am J Hum Genet       Date:  1995-05       Impact factor: 11.025

10.  The gene for X-linked myotubular myopathy is located in an 8 Mb region at the border of Xq27.3 and Xq28.

Authors:  E A Janssen; G W Hensels; B A van Oost; B C Hamel; S Kemp; F Baas; J W Weber; P G Barth; P A Bolhuis
Journal:  Neuromuscul Disord       Date:  1994 Sep-Nov       Impact factor: 4.296

View more
  21 in total

1.  A mutation in the MTM1 gene invalidates a previous suggestion of nonallelic heterogeneity in X-linked myotubular myopathy.

Authors:  C Guiraud-Chaumeil; M C Vincent; J Laporte; M Fardeau; F Samson; J L Mandel
Journal:  Am J Hum Genet       Date:  1997-06       Impact factor: 11.025

2.  Myotubularin, a protein tyrosine phosphatase mutated in myotubular myopathy, dephosphorylates the lipid second messenger, phosphatidylinositol 3-phosphate.

Authors:  G S Taylor; T Maehama; J E Dixon
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

3.  Extensive germinal mosaicism in a family with X linked myotubular myopathy simulates genetic heterogeneity.

Authors:  M C Vincent; C Guiraud-Chaumeil; J Laporte; S Manouvrier-Hanu; J L Mandel
Journal:  J Med Genet       Date:  1998-03       Impact factor: 6.318

4.  Comparative mapping on the mouse X chromosome defines a myotubular myopathy equivalent region.

Authors:  B de Gouyon; A Chatterjee; A Monaco; N Quaderi; S D Brown; G E Herman
Journal:  Mamm Genome       Date:  1996-08       Impact factor: 2.957

Review 5.  Synthesis and function of membrane phosphoinositides in budding yeast, Saccharomyces cerevisiae.

Authors:  Thomas Strahl; Jeremy Thorner
Journal:  Biochim Biophys Acta       Date:  2007-02-06

Review 6.  Misregulation of alternative splicing causes pathogenesis in myotonic dystrophy.

Authors:  N Muge Kuyumcu-Martinez; Thomas A Cooper
Journal:  Prog Mol Subcell Biol       Date:  2006

7.  Autosomal dominant centronuclear myopathy with unique clinical presentations.

Authors:  Jee Young Lee; Ju Hong Min; Yoon Ho Hong; Jung Joon Sung; Sung Hye Park; Seong Ho Park; Kwang Woo Lee; Kyung Seok Park
Journal:  J Korean Med Sci       Date:  2007-12       Impact factor: 2.153

8.  The cnm locus, a canine homologue of human autosomal forms of centronuclear myopathy, maps to chromosome 2.

Authors:  Laurent Tiret; Stéphane Blot; Jean-Louis Kessler; Hugues Gaillot; Matthew Breen; Jean-Jacques Panthier
Journal:  Hum Genet       Date:  2003-07-23       Impact factor: 4.132

9.  T-tubule disorganization and defective excitation-contraction coupling in muscle fibers lacking myotubularin lipid phosphatase.

Authors:  Lama Al-Qusairi; Norbert Weiss; Anne Toussaint; Céline Berbey; Nadia Messaddeq; Christine Kretz; Despina Sanoudou; Alan H Beggs; Bruno Allard; Jean-Louis Mandel; Jocelyn Laporte; Vincent Jacquemond; Anna Buj-Bello
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-21       Impact factor: 11.205

10.  Defective autophagy and mTORC1 signaling in myotubularin null mice.

Authors:  Kristina M Fetalvero; Yenyen Yu; Margaret Goetschkes; Guiqing Liang; Reginald A Valdez; Ty Gould; Ellen Triantafellow; Sebastian Bergling; Joseph Loureiro; John Eash; Victor Lin; Jeffrey A Porter; Peter M Finan; Kenneth Walsh; Yi Yang; Xiaohong Mao; Leon O Murphy
Journal:  Mol Cell Biol       Date:  2012-10-29       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.